Share Price | Cardio Diagnostics Holdings, Inc. Stock Analysis & Recommendation

Q: What does Cardio Diagnostics Holdings, Inc. do?

Overview: Cardio Diagnostics Holdings, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) Market-cap: USD 6.47 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.81 Return on Equity: -51.46% Price to Book: 0.57Contact Details: Registrar Address: Not available.

Q: Is Cardio Diagnostics Holdings, Inc. technically bullish or bearish?

As of 1 July 2025, the technical trend for Cardio Diagnostics Holdings, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearishness, while the weekly and monthly MACD and OBV show mildly bullish signals. However, Bollinger Bands are also indicating a mildly bearish trend. The stock has underperformed significantly year-to-date and over the past year compared to the S&P 500, with returns of -85.9% and -52.97% respectively, against the benchmark's 12.22% and 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

344.97 k

Shareholding (Sep 2025)

FII

0.15%

Held by 4 FIIs

DII

97.83%

Held by 2 DIIs

Promoter

0.03%

How big is Cardio Diagnostics Holdings, Inc.?

22-Jun-2025

As of Jun 18, Cardio Diagnostics Holdings, Inc. has a market capitalization of 6.47 million and reported net sales of 0.02 million with a net profit of -5.86 million over the latest four quarters. Shareholder's funds are 9.56 million, and total assets amount to 10.62 million.

View full answer

What does Cardio Diagnostics Holdings, Inc. do?

22-Jun-2025

Cardio Diagnostics Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025. Key metrics include a market cap of $6.47 million and a return on equity of -51.46%.

View full answer

Is Cardio Diagnostics Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of July 1, 2025, Cardio Diagnostics Holdings, Inc. has a mildly bearish trend, influenced by daily moving averages, while year-to-date and annual returns are significantly underperforming the S&P 500 at -85.9% and -52.97%, respectively.

View full answer

Compare Cardio Diagnostics Holdings, Inc. with Similar Stocks

Heart Test Laboratories, Inc.Bluejay Diagnostics, Inc.GlucoTrack, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 3 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.75

Return on Equity

-80.38%

Price to Book

0.41

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Sep 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

214.63%

6 Months

19.44%

1 Year

108.06%

2 Years

-7.19%

3 Years

-87.04%

4 Years

0.0%

5 Years

0.0%

Cardio Diagnostics Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-93.54%

EBIT Growth (5y)

-136.86%

EBIT to Interest (avg)

-1.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.81

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.19%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.73

EV to EBIT

0.17

EV to EBITDA

0.18

EV to Capital Employed

-0.46

EV to Sales

-0.97

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-51.46%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (2.0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.00% vs -6.25% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-1.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.70",
          "val2": "-1.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-599,508.60%",
          "val2": "-224,575.10%",
          "chgp": "-37,493.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs -78.72% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.10",
          "val2": "-7.10",
          "chgp": "-14.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "6.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.40",
          "val2": "-8.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-239,778.60%",
          "val2": "-424,404.30%",
          "chgp": "18,462.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.60

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.70

Operating Profit Margin (Excl OI)

-599,508.60%

-224,575.10%

-37,493.35%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -6.25% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-8.10

-7.10

-14.08%

Interest

0.00

6.70

-100.00%

Exceptional Items

0.00

5.60

-100.00%

Consolidate Net Profit

-8.40

Operating Profit Margin (Excl OI)

-239,778.60%

-424,404.30%

18,462.57%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 0.00% vs -78.72% in Dec 2023

All Annual Results

Company CV

About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Cardio Diagnostics Holdings, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cardio Diagnostics Holdings, Inc.?

Watch in Real-Time

What does Cardio Diagnostics Holdings, Inc. do?

Is Cardio Diagnostics Holdings, Inc. technically bullish or bearish?

Compare Cardio Diagnostics Holdings, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Cardio Diagnostics Holdings, Inc.

Company Coordinates